Richard Aldrich Insider Profile

11 Followers
Richard Aldrich, Director at Tempest Therapeutics, holds 0.00 shares in Concert Pharma (Ticker: CNCE), holds 136.85K shares in Tempest Therapeutics (Ticker: TPST), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV).
tipranks
Richard Aldrich

Richard Aldrich
Tempest Therapeutics (TPST)
Director

Ranked #94,536 out of 99,218 Corporate Insiders

Profitable Transactions

18%
3 out of 17 Profitable Transactions

Average Return

-31.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
94.61%
5.39%
0.00%
0.00%
A breakdown of Richard Aldrich's holdings

Insider Roles

Verastem
(VSTM)
Director
Tempest Therapeutics
(TPST)
Director
KalVista Pharmaceuticals
(KALV)
Director
PTC Therapeutics
(PTCT)
Director
Roles that Richard Aldrich holds in companies

Most Profitable Insider Trade

Stock:
Tempest Therapeutics
(TPST)
Rating:Informative Buy
Date:Mar 11, 2014 - Mar 11, 2015
Return:+347.50%
The most profitable trade made by Richard Aldrich

Richard Aldrich's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
Dec 11, 2018
Director
Uninformative Buy
$145.06K
KalVista Pharmaceuticals
Oct 19, 2017
Director
Informative Buy
4.87M
CNCE
Concert Pharma
Mar 06, 2023
Uninformative Sell
$0.00
PTC Therapeutics
Jun 10, 2015
Director
Uninformative Sell
389.59K
$0.00
Verastem
May 20, 2014
Director
Informative Buy
8.37K
$2.55M
EPRSQ
Epirus Biopharma
$0.00
List of latest transactions for each holding click on a transaction to see Richard Aldrich's performance on stock

Richard Aldrich insider profile FAQ

What is the percentage of profitable transactions made by Richard Aldrich?
The percentage of profitable transactions made by Richard Aldrich is 18%.
    What is the average return per transaction made by Richard Aldrich?
    The average return per transaction made by Richard Aldrich is -31.90%.
      What stocks does Richard Aldrich hold?
      Richard Aldrich holds: TPST, KALV, CNCE, PTCT, VSTM, EPRSQ stocks.
        What was Richard Aldrich’s latest transaction?
        Richard Aldrich latest transaction was an Uninformative Sell of ―.
          What was Richard Aldrich's most profitable transaction?
          Richard Aldrich’s most profitable transaction was an Informative Buy of TPST stock on March 11, 2014. The return on the trade was 347.50%.
            What is Richard Aldrich's role in Tempest Therapeutics?
            Richard Aldrich's role in Tempest Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.